Joseph Fargnoli Selected Research

Antineoplastic Agents (Antineoplastics)

12/2008

Synergistic antitumor activity of ixabepilone (BMS-247550) plus bevacizumab in multiple in vivo tumor models.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Joseph Fargnoli Research Topics

Disease

14	Neoplasms (Cancer) 02/2021 - 04/2006
5	Carcinoma (Carcinomatosis) 05/2010 - 06/2006
2	Melanoma (Melanoma, Malignant) 11/2015 - 07/2015
2	Breast Neoplasms (Breast Cancer) 06/2010 - 12/2008
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2016
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2016
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2016
1	Rhabdomyosarcoma 09/2010
1	Resistance To Insulin-Like Growth Factor I 09/2010
1	Sarcoma (Soft Tissue Sarcoma) 09/2010
1	Necrosis 06/2010
1	Kidney Neoplasms (Kidney Cancer) 12/2008
1	Neoplasm Metastasis (Metastasis) 12/2008
1	Hepatocellular Carcinoma (Hepatoma) 10/2008

Drug/Important Bio-Agent (IBA)

8	Phosphotransferases (Kinase)IBA 06/2011 - 04/2006
6	brivanibIBA 06/2010 - 04/2006
4	Proteins (Proteins, Gene)FDA Link 11/2015 - 07/2007
3	Angiogenesis InhibitorsIBA 06/2010 - 07/2007
2	Caspase 3 (Caspase-3)IBA 11/2015 - 07/2015
2	ProdrugsIBA 12/2009 - 04/2006
2	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 12/2009 - 07/2007
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 10/2008 - 07/2007
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 02/2021
1	DioxygenasesIBA 02/2021
1	linrodostatIBA 02/2021
1	EnzymesIBA 02/2021
1	Heme (Haem)IBA 02/2021
1	quinone (benzoquinone)IBA 01/2016
1	Inhibitor of Apoptosis ProteinsIBA 07/2015
1	Aligeron (AS 2)IBA 07/2015
1	LipidsIBA 11/2011
1	Small Interfering RNA (siRNA)IBA 11/2011
1	Protein Isoforms (Isoforms)IBA 11/2011
1	Fatty Acids (Saturated Fatty Acids)IBA 11/2011
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 11/2011
1	Stearoyl-CoA DesaturaseIBA 11/2011
1	BMS-690514IBA 06/2011
1	matrigelIBA 06/2011
1	AntibodiesIBA 09/2010
1	BMS 754807IBA 09/2010
1	Insulin ReceptorIBA 09/2010
1	IGF Type 1 Receptor (IGF 1 Receptor)IBA 09/2010
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 09/2010
1	Tamoxifen FDA LinkGeneric 06/2010
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 02/2010
1	Gadolinium DTPA (Magnevist)FDA Link 02/2010
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 02/2010
1	Contrast MediaIBA 02/2010
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2010
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 02/2010
1	Antineoplastic Agents (Antineoplastics)IBA 12/2008
1	Paclitaxel (Taxol)FDA LinkGeneric 12/2008
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 12/2008
1	Epothilones (Epothilone)IBA 12/2008
1	Sunitinib (Sutent)FDA Link 12/2008
1	Bevacizumab (Avastin)FDA Link 12/2008
1	ixabepilone (BMS 247550)FDA Link 12/2008
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 10/2008
1	Tyrosine (L-Tyrosine)FDA Link 10/2008
1	5- isopropyl- 6- (5- methyl- 1,3,4- oxadiazol- 2- yl)- N- (2- methyl- 1H- pyrrolo(2,3- b)pyridin- 5- yl)pyrrolo(2,1- f)(1,2,4)triazin- 4- amineIBA 05/2008
1	AmidesIBA 03/2008
1	malonamideIBA 03/2008
1	Tyrosine Kinase InhibitorsIBA 07/2007
1	Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA 07/2007
1	RNA (Ribonucleic Acid)IBA 07/2007
1	Biological ProductsIBA 07/2007
1	Biomarkers (Surrogate Marker)IBA 07/2007
1	Alanine (L-Alanine)FDA Link 04/2006

Therapy/Procedure

4	Therapeutics 02/2015 - 12/2008
1	Immunotherapy 02/2021
1	Oral Administration 03/2009
1	Drug Therapy (Chemotherapy) 12/2008